Rosiglitazone reduces angiotensin II and advanced glycation end product-dependent sustained nuclear factor-kappaB activation in cultured human proximal tubular epithelial cells.

Hormone and metabolic research. Hormon- und Stoffwechselforschung. Hormones et métabolisme

Volumn 40, Issue 11, 2008, Pages 752-759

  Morcos, M ^a   Schlotterer, A ^a   Sayed, A A ^a   Kukudov, G ^a   Oikomonou, D ^a   Ibrahim, Y ^a   Pfisterer, F ^a   Schneider, J ^a   Bozorgmehr, F ^a   Rudofsky Jr , G ^a   Schwenger, V ^a   Kientsch Engels, R ^a   Hamann, A ^a   Zeier, M ^a   Dugi, K ^a   Yard, B ^a   Humpert, P M ^a   van der Woude, F ^a   Nawroth, P P ^a   Bierhaus, A ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; 3 NITROTYROSINE; 3-NITROTYROSINE; ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCOSYLATION END PRODUCT RECEPTOR; ADVANCED GLYCOSYLATION END-PRODUCT RECEPTOR; ANGIOTENSIN II; ANTIDIABETIC AGENT; DRUG DERIVATIVE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOGLOBULIN RECEPTOR; ROSIGLITAZONE; TYROSINE; UNCLASSIFIED DRUG;

ARTICLE; BIOSYNTHESIS; CELL CULTURE; CELL NUCLEUS; CHEMISTRY; DIABETIC NEPHROPATHY; EPITHELIUM CELL; GENE EXPRESSION; GENETICS; HUMAN; KIDNEY PROXIMAL TUBULE; METABOLISM; OXIDATIVE STRESS; PHYSIOLOGY;

ANGIOTENSIN II; CELL NUCLEUS; CELLS, CULTURED; DIABETIC NEPHROPATHIES; EPITHELIAL CELLS; GENE EXPRESSION; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; HYPOGLYCEMIC AGENTS; KIDNEY TUBULES, PROXIMAL; NF-KAPPA B; OXIDATIVE STRESS; RECEPTORS, IMMUNOLOGIC; THIAZOLIDINEDIONES; TYROSINE;

EID: 59849100342     PISSN: 00185043     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0028-1082039     Document Type: Article

References (0)